New study aims to reduce bleeding risk in High-Stakes liver transplants
NCT ID NCT07304466
Summary
This study aims to see which of two drugs, terlipressin or somatostatin, works better to lower dangerously high blood pressure in the liver's main vein during a living donor liver transplant. Researchers will measure how much each drug reduces this pressure, and whether this leads to less bleeding and fewer blood transfusions during the surgery. The study will involve 50 patients with severe liver disease who are scheduled for this type of transplant.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PORTAL HYPERTENSION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.